Journal Article

Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults

Riviere, Cynthia, Santos, Breno, Bollinger, Robert C., Gupte, Nikhil, Tripathy, Srikanth, Balagopal, Ashwin, Thomas, David L., Kumarasamy, Nagalingeswaran, Smeaton, Laura, Sugandhavesa, Patcharaphan, Asmuth, David M., Cardoso, Sandra W., Gupta, Amita, Andrade, Bruno B., Campbell, Thomas B., Hakim, James, Erlandson, Kristine M., Infante, Rosa, Hosseinipour, Mina C., Berendes, Sima, Mave, Vidya, Mwelase, Noluthando, Pillay, Sandy

2016

Overview

Background. Both wasting and obesity are associated with inflammation, but the extent to which body weight changes influence inflammation during human immunodeficiency virus infection is unknown. Methods. Among a random virologically suppressed participants of the Prospective Evaluation of Antiretrovirals in Resource-Limited Settings trial, inflammatory markers were measured at weeks 0, 24, and 48 after antiretroviral therapy (ART) initiation. Associations between both baseline and change in body mass index (BMI; calculated as the weight in kilograms divided by the height in meters squared) and changes in inflammation markers were assessed using random effects models. Results. Of 246 participants, 27% were overweight/obese (BMI, ≥ 25), and 8% were underweight (BMI < 18.5) at baseline. After 48 weeks, 37% were overweight/obese, and 3% were underweight. While level of many inflammatory markers decreased 48 weeks after ART initiation in the overall group, the decrease in C-reactive protein (CRP) level was smaller in overweight/obese participants (P = .01), and the decreases in both CRP (P = .01) and interleukin 18 (P = .02) levels were smaller in underweight participants. Each 1-unit gain in BMI among overweight/obese participants was associated with a 0.02-log10 increase in soluble CD14 level (P = .05), while each 1-unit BMI gain among underweight participants was associated with a 9.32-mg/L decrease in CRP level (P = .001). Conclusions. Being either overweight or underweight at ART initiation was associated with heightened systemic inflammation. While weight gain among overweight/obese persons predicted increased inflammation, weight gain among underweight persons predicted reduced inflammation.

• Publisher: Oxford University Press
• Subject: Adult / Anti-HIV Agents - adverse effects / Anti-HIV Agents - therapeutic use / Body Weight - drug effects / Brazil / Cohort Studies / Female / Haiti / HIV Infections - drug therapy / HIV/AIDS / Human immunodeficiency virus / Humans / India / Inflammation - chemically induced / Major and Brief Reports / Malawi / Male / Peru / Prospective Studies / South Africa / Thailand / United States / Weight Gain - drug effects / Weight Loss - drug effects / Zimbabwe